Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (301-310 of 399) with videos related to

Pageof 40
Sort By:
Blood|October 29, 2005
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421David Becton, Gary V Dahl, Yaddanapudi Ravindranath, et al.
British Journal of Haematology|October 9, 2003
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemiaElaine Coustan-Smith, Raul C Ribeiro, Jeffrey E Rubnitz, et al.
Nature Genetics|August 18, 2009
Germline genomic variants associated with childhood acute lymphoblastic leukemiaLisa R Treviño, Wenjian Yang, Deborah French, et al.
Blood|July 5, 2017
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531Erin M Guest, Richard Aplenc, Lillian Sung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseasesR A Krance, C A Hurwitz, D R Head, et al.
Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Blood|August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG reportFabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Cancer Genetics and Cytogenetics|March 11, 2008
Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-EoMaria Luiza Macedo Silva, Susana C Raimondi, Eliana Abdelhay, et al.
Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Pageof 40

Showing results (301-310 of 399) with videos related to

Sort By:
Pageof 40
Blood|October 29, 2005
Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421David Becton, Gary V Dahl, Yaddanapudi Ravindranath, et al.
British Journal of Haematology|October 9, 2003
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemiaElaine Coustan-Smith, Raul C Ribeiro, Jeffrey E Rubnitz, et al.
Nature Genetics|August 18, 2009
Germline genomic variants associated with childhood acute lymphoblastic leukemiaLisa R Treviño, Wenjian Yang, Deborah French, et al.
Blood|July 5, 2017
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531Erin M Guest, Richard Aplenc, Lillian Sung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseasesR A Krance, C A Hurwitz, D R Head, et al.
Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Blood|October 7, 2000
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemiaE Coustan-Smith, J Sancho, M L Hancock, et al.
Blood|August 23, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG reportFabiana Ostronoff, Megan Othus, Robert B Gerbing, et al.
Cancer Genetics and Cytogenetics|March 11, 2008
Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-EoMaria Luiza Macedo Silva, Susana C Raimondi, Eliana Abdelhay, et al.
Pediatric Blood & Cancer|August 12, 2016
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology GroupRanjani Ramamurthy, Maya Hughes, Valerie Morris, et al.
Pageof 40